Compare ADXN & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADXN | RVSN |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | Switzerland | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 8.9M |
| IPO Year | 2019 | 2018 |
| Metric | ADXN | RVSN |
|---|---|---|
| Price | $3.40 | $3.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 96.0K | 18.2K |
| Earning Date | 04-30-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $86.57 | $860.32 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.10 | $0.17 |
| 52 Week High | $11.97 | $9.39 |
| Indicator | ADXN | RVSN |
|---|---|---|
| Relative Strength Index (RSI) | 33.77 | 31.87 |
| Support Level | N/A | $0.28 |
| Resistance Level | $7.37 | $5.09 |
| Average True Range (ATR) | 0.28 | 0.32 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 31.01 | 12.88 |
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
Rail Vision Ltd is an early commercialization stage technology company focused on railway safety systems using AI-integrated sensing systems. The company develops and commercializes proprietary, multi-spectral electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, the company's technology enhances safety, improves operational efficiency, and supports continuity across deployments.